Nuclear entrapment of BCR-ABL by combining imatinib mesylate with leptomycin B does not eliminate CD34+ chronic myeloid leukaemia cells

Allan, E.K., Hamilton, A., Hatziieremia, S., Zhou, P., Jorgensen, H.G., Vigneri, P. and Holyoake, T.L. (2009) Nuclear entrapment of BCR-ABL by combining imatinib mesylate with leptomycin B does not eliminate CD34+ chronic myeloid leukaemia cells. Leukemia, 23(5), pp. 1006-1008. (doi:10.1038/leu.2008.367)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1038/leu.2008.367

Abstract

No abstract available.

Item Type:Articles (Letter)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Hamilton, Ms Ashley and Holyoake, Professor Tessa and Allan, Mrs Elaine and Jorgensen, Dr Heather and Hatziieremia, Dr Sophia
Authors: Allan, E.K., Hamilton, A., Hatziieremia, S., Zhou, P., Jorgensen, H.G., Vigneri, P., and Holyoake, T.L.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Leukemia
Publisher:Nature Publishing Group
ISSN:0887-6924
ISSN (Online):1476-5551
Published Online:08 January 2009
Related URLs:

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
439231Is Bcr-Able expression relevant for the survival of cancer stem cells in chronic myeloid leukaemiaTessa HolyoakeMedical Research Council (MRC)G0600782Institute of Cancer Sciences